T. Rowe Price Investment Management, Inc. Abb Vie Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 4,825,713 shares of ABBV stock, worth $937 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
4,825,713
Previous 4,836,882
0.23%
Holding current value
$937 Million
Previous $881 Million
6.03%
% of portfolio
0.52%
Previous 0.54%
Shares
7 transactions
Others Institutions Holding ABBV
# of Institutions
3,692Shares Held
1.27BCall Options Held
13MPut Options Held
9.79M-
Vanguard Group Inc Valley Forge, PA171MShares$33.1 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.1 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.4 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.5 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $343B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...